Correlation Between Vitrolife and NextCell Pharma
Can any of the company-specific risk be diversified away by investing in both Vitrolife and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and NextCell Pharma AB, you can compare the effects of market volatilities on Vitrolife and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and NextCell Pharma.
Diversification Opportunities for Vitrolife and NextCell Pharma
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vitrolife and NextCell is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of Vitrolife i.e., Vitrolife and NextCell Pharma go up and down completely randomly.
Pair Corralation between Vitrolife and NextCell Pharma
Assuming the 90 days trading horizon Vitrolife AB is expected to under-perform the NextCell Pharma. In addition to that, Vitrolife is 1.26 times more volatile than NextCell Pharma AB. It trades about -0.09 of its total potential returns per unit of risk. NextCell Pharma AB is currently generating about 0.04 per unit of volatility. If you would invest 173.00 in NextCell Pharma AB on September 1, 2024 and sell it today you would earn a total of 2.00 from holding NextCell Pharma AB or generate 1.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Vitrolife AB vs. NextCell Pharma AB
Performance |
| Timeline |
| Vitrolife AB |
| NextCell Pharma AB |
Vitrolife and NextCell Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vitrolife and NextCell Pharma
The main advantage of trading using opposite Vitrolife and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.| Vitrolife vs. Flexion Mobile PLC | Vitrolife vs. Arctic Blue Beverages | Vitrolife vs. Online Brands Nordic | Vitrolife vs. Invisio Communications AB |
| NextCell Pharma vs. Diamyd Medical AB | NextCell Pharma vs. Mendus AB | NextCell Pharma vs. Vicore Pharma Holding | NextCell Pharma vs. Immunovia publ AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |